Skin Excision EvaluationProgram Instructions

Enrolment and getting startedOnce you are enrolled we will forward you the required resources for you to commence submission of your histology

samples – contributing to your CPD program requirements. Your Clinical Labs representative may also have provided you

with the specific ‘Skin Excision Evaluation Program request form’ when you completed the program registration form.

1

Request form completionPlease note that coding must be entered on the reverse of the

form for program inclusion - clinical notes included on the front

of the form is not considered adequate. The request form is

structured to clearly separate your patients biopsies from patient

excisions. Biopsy specimens in which the goal is simply diagnosis

do not have margins recorded in the audit, but excisions do.

2

Program criteriaYou must submit 40 histology samples per 12 month cycle

(excision or biopsy) using the Skin Excision Evaluation Program

request form (pictured left) with all clinical coding provided on

the reverse. Completion of an assessment and evaluation activity

are also required for program completion.

3

PATHOLOGY PATIENT BILLING POLICY: Australian Clinical Labs reserves the right to privately bill all Tests listed and unlisted in

the Medicare Benefits Schedule.

1300 453 688 | ClinicalLabs.com.au

1300 453 688 | ClinicalLabs.com.au

Instructions: Please ensure each specimen is clearly numbered and the details are recorded below.

LAB NO. & IMAGE BOTH SIDES OF REQUEST FORMSKIN EXCISION EVALUATION PROGRAM

SKIN EXCISION EVALUATION PROGRAM

ACLZFRM0025 ACLMAR-REQ-NAT-0025.7 07/17

Body Region Code

Nose NO

Lip LI

Ear EA

Eyelid EY

Other face OF

Scalp SC

Neck NE

Shoulder SH

Chest CH

Abdomen AB

Back BA

Buttock BU

Genitalia GE

Arm AR

Forearm (elbow & below) FO

Hand HA

Provisional Diagnosis or Previous Result

Code

Atypical Fibroxanthoma

AF

Basal Cell carcinoma BC

Benign other BO

Dermatofibroma DF

Epidermal cyst EC

Provisional Diagnosis or Previous Result

Code

Fibroepithelial polyp / skin tag

FE

Haemangioma HA

Inflammatory lesion IL

Keratoacanthoma KA

Keratosis, benign KB

Lentigo LE

Lipoma LI

Malignant other MO

Melanoma in situ / HMF / lentigo maligna MS

Melanoma, invasive MM

Merkel Cell Carcinoma

MC

Naevus, Benign melanocytic

NB

Excision Type Code

Conventional full thickness excision

CE

Punch excision PE

Shave excision SE

Other excision OE

Biopsy Type Code

Punch P

Shave S

Incisional I

Curettage C

Other O

Body Region Code

Palm PM

Finger FI

Upper Leg (above knee)

UL

Leg (knee & below) LE

Foot FT

Toe TO

Sole SO

Provisional Diagnosis or Previous Result

Code

Naevus, Blue NL

Naevus, Dysplastic ND

Naevus, Spitz NS

Neurofibroma NF

Pilar cyst PC

Scar SR

SCC in situ / Bowens / intraepidermal carcinoma

SI

Seborrhoeic keratosis SB

Solar keratosis SO

Squamous Cell Carcinoma, invasive SC

Viral wart VW

Body Region See key

Provisional DiagnosisSee key

New Lesion Previous DiagnosisSee key

Biopsy TypeSee key

Excision TypeSee key

Dermoscopy

e.g. AR NB Y n/a - CE Y

1

2

3

4

5

6

LeftRightLeft Side

RightLeft

Left Eye

Left

Right Side

Right Eye

Right

Right Foot

Right Hand

Right Palm

Left Foot

Left Hand

Left Palm

Left Right

Find your way to better health

KEY

CPD point allocationIf you’ve reached the criteria, your activity points will be uploaded to the appropriate college for recognition. You’ll receive

an email notifying you of your success. Keep in mind multiple cycles are achievable if you continue to participate in the

program throughout the 3 years of the triennium.

5

Skin Excision Evaluation Reports4Reporting on successfully submitted skin excisions allows

participants to download the charts and tables to support

ongoing education. A feature of this program allows participants

to confidentially review their progress with peers, as well as state

and national benchmarks. To access these reports you will need

to login to: www.clinicallabs.com.au/harp (your login details will

be emailed to you).

1300 134 111 VIC NSW SA NT

1300 367 674 Western Australia

clinicallabs.com.au

LEARNING OBJECTIVES

Compare personal diagnostic and surgical proficiency

with state and national peer groups.

Detect cases which require

additional treatment to ensure the

ongoing care & safety of patients.

Compare personal melanoma detection rates

with state and national peer groups.

Identify diagnostic inaccuracies

concerning skin lesions submitted for

histo-pathological analysis.

Demonstrate appropriate surgical

margin practices for malignant skin

cancer procedures.

ACM

AR-B

F-NA

T-01

97.6

02/

20 A

CLZL

FT00

49

MS MM SI SC BC NDYou 0% 0%Peers 0% 67% 25% 39% 51% 10%All participants 17% 80% 30% 44% 63% 12%Peers (NAT) 15% 50% 33% 32% 50% 21%All participants (NAT) 15% 12% 29% 25% 56% 34%

%

0%10%

20%

30%

40%50%

60%70%80%

90%

100%

Diagnostic Accuracy

(SA)

(SA) MS MM SI SC BC NDComplete 100% 100%Incomplete 0% 0%

0%

10%

20%

30%

40%50%

60%70%

80%

90%

100%

%

Margin Adequacy

Our Diagnostic Accuracy chart above presents you a

comparison between the precision of your provisional

assessment in contrast to your peers and against all other

participants in your state and nationally.

The chart above helps you compare the percentage

between the complete and incomplete margins amongst

the excisions submitted based on type.

Number of Specimens Total

17

New lesions 10

Previously biopsied lesions 0

Total lesions for this interval 19

Melanoma Data Your total Peer group Peer group (NAT)

HSPtotal

MS 0 0 9 39

Melanoma, invasive MM 0 5 10 32

total (SA)

In this table, you can view a breakdown of the number of

samples you have provided to the program for the month.

Through the Melanoma Data table, you can compare

your number of patients diagnosed with invasive and

non-invasive melanomas against your peers and all other

participants in your state as well as nationwide.

The Provisional vs. Histological table allows you to assess the overall results of your provisional diagnosis once histology

has been completed for you to determine areas for improvement.

Assessment Tools6

This activity is approved by the RACGP for 40 Cat 1 CPD

QI points and ACRRM 30 PRDP points. Australian Clinical Labs

is an approved activity provider with the RACGP - AAP # 184667.